GW’s Epidiolex Leaps Another Hurdle
GW Pharmaceuticals Announces Second Positive Phase 3 Pivotal Trial for Epidiolex(R) (cannabidiol)...
Read MoreGW Pharmaceuticals Announces Second Positive Phase 3 Pivotal Trial for Epidiolex(R) (cannabidiol)...
Read MoreAnalysis of “big data” shows a protective effect for cannabis with respect to a wide...
Read MoreNancy Sajben, MD, forwards a snarky story from The Guardian that asserts, “The main psychoactive ingredient in marijuana makes lab rats lazy, according to University of British Columbia researchers.”The UBC...
Read MoreAddiction Specialist Alan Budney explains in the new journal Cannabis and Cannabinoid Research,...
Read MoreBy Martin A. LeeIn late June, 297 delegates from 24 countries attended the 26th annual conference...
Read More